DAIHAN Scientific Statistics

Total Valuation

DAIHAN Scientific has a market cap or net worth of KRW 37.04 billion. The enterprise value is 40.94 billion.

Market Cap	37.04B
Enterprise Value	40.94B

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

DAIHAN Scientific has 7.45 million shares outstanding. The number of shares has decreased by -1.12% in one year.

Shares Outstanding	7.45M
Shares Change (YoY)	-1.12%
Shares Change (QoQ)	-6.91%
Owned by Insiders (%)	34.43%
Owned by Institutions (%)	n/a
Float	4.40M

Valuation Ratios

The trailing PE ratio is 13.66.

PE Ratio	13.66
Forward PE	n/a
PS Ratio	0.50
PB Ratio	0.94
P/FCF Ratio	13.53
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.61, with an EV/FCF ratio of 14.96.

EV / Earnings	15.98
EV / Sales	0.58
EV / EBITDA	6.61
EV / EBIT	9.40
EV / FCF	14.96

Financial Position

The company has a current ratio of 3.59, with a Debt / Equity ratio of 0.04.

Current Ratio	3.59
Quick Ratio	1.19
Debt / Equity	0.04
Debt / EBITDA	0.34
Debt / FCF	0.77
Interest Coverage	28.69

Financial Efficiency

Return on equity (ROE) is 8.00% and return on invested capital (ROIC) is 5.35%.

Return on Equity (ROE)	8.00%
Return on Assets (ROA)	4.34%
Return on Capital (ROIC)	5.35%
Revenue Per Employee	614.22M
Profits Per Employee	22.28M
Employee Count	115
Asset Turnover	1.13
Inventory Turnover	1.90

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.05% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-20.05%
50-Day Moving Average	5,116.30
200-Day Moving Average	5,712.23
Relative Strength Index (RSI)	48.20
Average Volume (20 Days)	20,138

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DAIHAN Scientific had revenue of KRW 70.64 billion and earned 2.56 billion in profits. Earnings per share was 363.90.

Revenue	70.64B
Gross Profit	20.42B
Operating Income	4.34B
Pretax Income	4.61B
Net Income	2.56B
EBITDA	6.18B
EBIT	4.34B
Earnings Per Share (EPS)	363.90

Full Income Statement

Balance Sheet

The company has 8.12 billion in cash and 2.11 billion in debt, giving a net cash position of 6.01 billion or 805.92 per share.

Cash & Cash Equivalents	8.12B
Total Debt	2.11B
Net Cash	6.01B
Net Cash Per Share	805.92
Equity (Book Value)	49.29B
Book Value Per Share	5,284.70
Working Capital	30.80B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.25 billion and capital expenditures -507.80 million, giving a free cash flow of 2.74 billion.

Operating Cash Flow	3.25B
Capital Expenditures	-507.80M
Free Cash Flow	2.74B
FCF Per Share	367.33

Full Cash Flow Statement

Margins

Gross margin is 28.92%, with operating and profit margins of 6.15% and 3.63%.

Gross Margin	28.92%
Operating Margin	6.15%
Pretax Margin	6.53%
Profit Margin	3.63%
EBITDA Margin	8.75%
EBIT Margin	6.15%
FCF Margin	3.88%

Dividends & Yields

This stock pays an annual dividend of 60.00, which amounts to a dividend yield of 1.21%.

Dividend Per Share	60.00
Dividend Yield	1.21%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	27.03%
Buyback Yield	1.12%
Shareholder Yield	2.33%
Earnings Yield	7.32%
FCF Yield	7.39%

Dividend Details

Stock Splits

The last stock split was on December 29, 2014. It was a forward split with a ratio of 1.07.

Last Split Date	Dec 29, 2014
Split Type	Forward
Split Ratio	1.07

Scores

DAIHAN Scientific has an Altman Z-Score of 4.74.

Altman Z-Score	4.74
Piotroski F-Score	n/a